Cargando…

Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study

INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Sijie, Wang, Zhi, Yang, Wenhan, Huang, Chuxin, Liu, Ping, Chen, Yanjing, Zhang, Huiting, Zhao, Guangju, Li, Weihui, Fang, Jiliang, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597483/
https://www.ncbi.nlm.nih.gov/pubmed/36312012
http://dx.doi.org/10.3389/fnins.2022.1018387
_version_ 1784816101186600960
author Yi, Sijie
Wang, Zhi
Yang, Wenhan
Huang, Chuxin
Liu, Ping
Chen, Yanjing
Zhang, Huiting
Zhao, Guangju
Li, Weihui
Fang, Jiliang
Liu, Jun
author_facet Yi, Sijie
Wang, Zhi
Yang, Wenhan
Huang, Chuxin
Liu, Ping
Chen, Yanjing
Zhang, Huiting
Zhao, Guangju
Li, Weihui
Fang, Jiliang
Liu, Jun
author_sort Yi, Sijie
collection PubMed
description INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of reaction time, and residual symptoms. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel and non-invasive treatment approach which stimulates brain structures with no side-effects. However, it remains little understood whether and how the neural activation is modulated by taVNS in MDD patients. Herein, we used the regional homogeneity (ReHo) to investigate the brain activity in first-episode, drug-naïve MDD patients after taVNS treatment. MATERIALS AND METHODS: Twenty-two first-episode, drug-naïve MDD patients were enrolled in the study. These patients received the first taVNS treatment at the baseline time, and underwent resting-state MRI scanning twice, before and after taVNS. All the patients then received taVNS treatments for 4 weeks. The severity of depression was assessed by the 17-item Hamilton Depression Rating Scale (HAMD) at the baseline time and after 4-week’s treatment. Pearson analysis was used to assess the correlation between alterations of ReHo and changes of the HAMD scores. Two patients were excluded due to excessive head movement, two patients lack clinical data in the fourth week, thus, imaging analysis was performed in 20 patients, while correlation analysis between clinical and imaging data was performed in only 18 patients. RESULTS: There were significant differences in the ReHo values in first-episode, drug-naïve MDD patients between pre- or post- taVNS. The primary finding is that the patients exhibited a significantly lower ReHo in the left/right median cingulate cortex, the left precentral gyrus, the left postcentral gyrus, the right calcarine cortex, the left supplementary motor area, the left paracentral lobule, and the right lingual gyrus. Pearson analysis revealed a positive correlation between changes of ReHo in the right median cingulate cortex/the left supplementary motor area and changes of HAMD scores after taVNS. CONCLUSION: The decreased ReHo were found after taVNS. The sensorimotor, limbic and visual-related brain regions may play an important role in understanding the underlying neural mechanisms and be the target brain regions in the further therapy.
format Online
Article
Text
id pubmed-9597483
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95974832022-10-27 Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study Yi, Sijie Wang, Zhi Yang, Wenhan Huang, Chuxin Liu, Ping Chen, Yanjing Zhang, Huiting Zhao, Guangju Li, Weihui Fang, Jiliang Liu, Jun Front Neurosci Neuroscience INTRODUCTION: Major depressive disorder (MDD) is a disease with prominent individual, medical, and economic impacts. Drug therapy and other treatment methods (such as Electroconvulsive therapy) may induce treatment-resistance and have associated side effects including loss of memory, decrease of reaction time, and residual symptoms. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel and non-invasive treatment approach which stimulates brain structures with no side-effects. However, it remains little understood whether and how the neural activation is modulated by taVNS in MDD patients. Herein, we used the regional homogeneity (ReHo) to investigate the brain activity in first-episode, drug-naïve MDD patients after taVNS treatment. MATERIALS AND METHODS: Twenty-two first-episode, drug-naïve MDD patients were enrolled in the study. These patients received the first taVNS treatment at the baseline time, and underwent resting-state MRI scanning twice, before and after taVNS. All the patients then received taVNS treatments for 4 weeks. The severity of depression was assessed by the 17-item Hamilton Depression Rating Scale (HAMD) at the baseline time and after 4-week’s treatment. Pearson analysis was used to assess the correlation between alterations of ReHo and changes of the HAMD scores. Two patients were excluded due to excessive head movement, two patients lack clinical data in the fourth week, thus, imaging analysis was performed in 20 patients, while correlation analysis between clinical and imaging data was performed in only 18 patients. RESULTS: There were significant differences in the ReHo values in first-episode, drug-naïve MDD patients between pre- or post- taVNS. The primary finding is that the patients exhibited a significantly lower ReHo in the left/right median cingulate cortex, the left precentral gyrus, the left postcentral gyrus, the right calcarine cortex, the left supplementary motor area, the left paracentral lobule, and the right lingual gyrus. Pearson analysis revealed a positive correlation between changes of ReHo in the right median cingulate cortex/the left supplementary motor area and changes of HAMD scores after taVNS. CONCLUSION: The decreased ReHo were found after taVNS. The sensorimotor, limbic and visual-related brain regions may play an important role in understanding the underlying neural mechanisms and be the target brain regions in the further therapy. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9597483/ /pubmed/36312012 http://dx.doi.org/10.3389/fnins.2022.1018387 Text en Copyright © 2022 Yi, Wang, Yang, Huang, Liu, Chen, Zhang, Zhao, Li, Fang and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Yi, Sijie
Wang, Zhi
Yang, Wenhan
Huang, Chuxin
Liu, Ping
Chen, Yanjing
Zhang, Huiting
Zhao, Guangju
Li, Weihui
Fang, Jiliang
Liu, Jun
Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title_full Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title_fullStr Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title_full_unstemmed Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title_short Neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: A resting-state fMRI study
title_sort neural activity changes in first-episode, drug-naïve patients with major depressive disorder after transcutaneous auricular vagus nerve stimulation treatment: a resting-state fmri study
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597483/
https://www.ncbi.nlm.nih.gov/pubmed/36312012
http://dx.doi.org/10.3389/fnins.2022.1018387
work_keys_str_mv AT yisijie neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT wangzhi neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT yangwenhan neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT huangchuxin neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT liuping neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT chenyanjing neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT zhanghuiting neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT zhaoguangju neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT liweihui neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT fangjiliang neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy
AT liujun neuralactivitychangesinfirstepisodedrugnaivepatientswithmajordepressivedisorderaftertranscutaneousauricularvagusnervestimulationtreatmentarestingstatefmristudy